MarketCap
Facebook
X
TelegramQuartalsbericht 2024-Q3
hinzugefügt 12.11.2024
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
5.74 M |
Marktkapitalisierung |
$ 15.3 M |
EBITDA (LTM) |
$ 123 K |
P/E (LTM) |
- |
P/S (LTM) |
0.73 |
EPS (LTM) |
-0.71 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
$ 16.65 | - | $ 179 M | Nasdaq Global Market |  China |
 |
Agilent Technologies
A
|
$ 113.98 | -0.78 % | $ 34.6 B | NYSE,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 24.15 | -2.23 % | $ 671 M | Nasdaq Global Market,SPB | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Co-Diagnostics
CODX
|
$ 1.61 | -1.21 % | $ 2.14 M | Nasdaq Capital Market | USA |
 |
CareDx, Inc
CDNA
|
$ 22.01 | 0.43 % | $ 1.17 B | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 15.24 | -0.39 % | $ 461 M | Nasdaq Global Market | USA |
 |
Illumina
ILMN
|
$ 125.07 | -1.46 % | $ 19.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Charles River Laboratories International
CRL
|
$ 167.08 | 0.22 % | $ 8.28 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Guardant Health
GH
|
$ 82.63 | -0.59 % | $ 10.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 82.9 | -0.78 % | $ 5.59 B | Nasdaq Global Select Market,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.93 | - | $ 8.54 M | Nasdaq Global Select Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 25.77 | -5.03 % | $ 20 B | NYSE |  Niderland |
 |
Personalis
PSNL
|
$ 5.34 | -2.92 % | $ 316 M | Nasdaq Global Select Market | USA |
 |
Senseonics Holdings
SENS
|
$ 7.03 | -2.09 % | $ 293 M | NYSE American | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Medpace Holdings
MEDP
|
$ 403.62 | -1.5 % | $ 11.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.18 | -0.46 % | $ 5.01 M | Nasdaq Capital Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
ICON Public Limited Company
ICLR
|
$ 111.86 | 9.14 % | $ 9.23 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
$ 260.29 | 0.29 % | $ 21.7 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.61 | -0.23 % | $ 61.9 M | Nasdaq Global Select Market | Irlanda |
 |
NeoGenomics
NEO
|
$ 9.6 | 6.43 % | $ 1.23 B | Nasdaq Global Select Market,SPB | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 57.42 | -2.92 % | $ 3.43 B | Nasdaq Global Select Market,SPB | USA |
 |
Celcuity
CELC
|
$ 118.83 | -1.04 % | $ 5.56 B | Nasdaq Global Select Market | USA |
 |
Neogen Corporation
NEOG
|
$ 9.19 | -1.61 % | $ 1.99 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 15.88 | -5.7 % | $ 355 M | Nasdaq Global Select Market | USA |
 |
Myriad Genetics
MYGN
|
$ 4.77 | -1.45 % | $ 442 M | Nasdaq Global Select Market,SPB | USA |
 |
Natera
NTRA
|
$ 196.02 | -2.08 % | $ 19.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 192.19 | -1.43 % | $ 21.3 B | NYSE,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Exagen
XGN
|
$ 2.68 | -1.83 % | $ 57.8 M | Nasdaq Global Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |